Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease

Abbott, 2006, Astrocyte-endothelial interactions at the blood-brain barrier, Nat. Rev. Neurosci., 7, 41, 10.1038/nrn1824 Banks, 2003, Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease, Neuroscience, 121, 487, 10.1016/S0306-4522(03)00474-3 Bateman, 2006, Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo, Nat. Med., 12, 856, 10.1038/nm1438 Bell, 2007, Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system, J. Cereb. Blood Flow Metab., 27, 909, 10.1038/sj.jcbfm.9600419 Blennow, 2004, Cerebrospinal fluid protein biomarkers for Alzheimer's disease, NeuroRx, 1, 213, 10.1602/neurorx.1.2.213 Boulton, 1996, Drainage of CSF through lymphatic pathways and arachnoid villi in sheep: measurement of 125I-albumin clearance, Neuropathol. Appl. Neurobiol., 22, 325, 10.1111/j.1365-2990.1996.tb01111.x Bradbury, 1985, The blood-brain barrier. Transport across the cerebral endothelium, Circ. Res., 57, 213, 10.1161/01.RES.57.2.213 Bradbury, 1983, Factors influencing exit of substances from cerebrospinal fluid into deep cervical lymph of the rabbit, J. Physiol., 339, 519, 10.1113/jphysiol.1983.sp014731 Brinker, 1997, Dynamic properties of lymphatic pathways for the absorption of cerebrospinal fluid, Acta Neuropathol., 94, 493, 10.1007/s004010050738 Bruggink, 2013, Amyloid-beta oligomer detection by ELISA in cerebrospinal fluid and brain tissue, Anal. Biochem., 433, 112, 10.1016/j.ab.2012.09.014 Cirrito, 2005, P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model, J. Clin. Invest., 115, 3285, 10.1172/JCI25247 Cirrito, 2005, Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo, Neuron, 48, 913, 10.1016/j.neuron.2005.10.028 Clifford, 2008, Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy, Brain Res., 1234, 158, 10.1016/j.brainres.2008.07.092 Deane, 2009, Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease, CNS Neurol. Disord. Drug Targets, 8, 16, 10.2174/187152709787601867 Deane, 2003, RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain, Nat. Med., 9, 907, 10.1038/nm890 Deane, 2008, apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain, J. Clin. Invest., 118, 4002, 10.1172/JCI36663 Deane, 2005, IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor, J. Neurosci., 25, 11495, 10.1523/JNEUROSCI.3697-05.2005 Deane, 2012, A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease, J. Clin. Invest., 122, 1377, 10.1172/JCI58642 Deane, 2015, Sleep deprivation disrupts apoE isoform specific radial diffusion from the penetrating arteries into brain by the glymphatic system, Vol. 461 Deane, 2004, LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms, Neuron, 43, 333, 10.1016/j.neuron.2004.07.017 Fagan, 2010, Cerebrospinal fluid biomarkers of Alzheimer's disease, Biomark. Med, 4, 51, 10.2217/bmm.09.83 Fagan, 2006, Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans, Ann. Neurol., 59, 512, 10.1002/ana.20730 Fagan, 2014, Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease, Sci. Transl. Med., 6, 10.1126/scitranslmed.3007901 Haj-Yasein, 2011, Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet, Proc. Natl. Acad. Sci. U. S. A., 108, 17815, 10.1073/pnas.1110655108 Hawkes, 2011, Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy, Acta Neuropathol., 121, 431, 10.1007/s00401-011-0801-7 Herrup, 2015, The case for rejecting the amyloid cascade hypothesis, Nat. Neurosci., 18, 794, 10.1038/nn.4017 Herz, 2009, Apolipoprotein E receptors in the nervous system, Curr. Opin. Lipidol., 20, 190, 10.1097/MOL.0b013e32832d3a10 Holtzman, 2012, Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease, Cold Spring Harb. Perspect. Med., 2, a006312, 10.1101/cshperspect.a006312 Iliff, 2014, Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury, J. Neurosci., 34, 16180, 10.1523/JNEUROSCI.3020-14.2014 Iliff, 2012, A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta, Sci. Transl. Med., 4, 10.1126/scitranslmed.3003748 Jaeger, 2009, Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition, J. Alzheimers Dis., 17, 553, 10.3233/JAD-2009-1074 Johanson, 2008, Multiplicity of cerebrospinal fluid functions: new challenges in health and disease, Cerebrospinal Fluid Res., 5, 10, 10.1186/1743-8454-5-10 Kanekiyo, 2014, The low-density lipoprotein receptor-related protein 1 and amyloid-beta clearance in Alzheimer's disease, Front. Aging Neurosci., 6, 93, 10.3389/fnagi.2014.00093 Kanekiyo, 2013, Neuronal clearance of amyloid-beta by endocytic receptor LRP1, J. Neurosci., 33, 19276, 10.1523/JNEUROSCI.3487-13.2013 Kanekiyo, 2012, LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-beta, J. Neurosci., 32, 16458, 10.1523/JNEUROSCI.3987-12.2012 Kayed, 2010, Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Abeta oligomers, Mol. Neurodegener., 5, 57, 10.1186/1750-1326-5-57 Kayed, 2003, Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science, 300, 486, 10.1126/science.1079469 Kida, 1993, CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance, Neuropathol. Appl. Neurobiol., 19, 480, 10.1111/j.1365-2990.1993.tb00476.x Kress, 2014, Impairment of paravascular clearance pathways in the aging brain, Ann. Neurol., 10.1002/ana.24271 Kumar-Singh, 2008, Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques, Genes Brain Behav., 7, 67, 10.1111/j.1601-183X.2007.00380.x Lue, 1999, Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am. J. Pathol., 155, 853, 10.1016/S0002-9440(10)65184-X Mathiisen, 2010, The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction, Glia, 58, 1094, 10.1002/glia.20990 Mawuenyega, 2010, Decreased clearance of CNS beta-amyloid in Alzheimer's disease, Science, 330, 1774, 10.1126/science.1197623 McLean, 1999, Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann. Neurol., 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M Michel, 1988, Capillary permeability and how it may change, J. Physiol., 404, 1, 10.1113/jphysiol.1988.sp017275 Musiek, 2015, Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’, Nat. Neurosci., 18, 800, 10.1038/nn.4018 Nedergaard, 2013, Neuroscience. Garbage truck of the brain, Science, 340, 1529, 10.1126/science.1240514 Niwa, 2001, A beta-peptides enhance vasoconstriction in cerebral circulation, Am. J. Physiol. Heart Circ. Physiol., 281, H2417, 10.1152/ajpheart.2001.281.6.H2417 Oe, 2006, Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry, Rapid Commun. Mass Spectrom., 20, 3723, 10.1002/rcm.2787 Paris, 2000, Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway, Neurobiol. Aging, 21, 183, 10.1016/S0197-4580(00)82162-4 Plog, 2015, Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system, J. Neurosci., 35, 518, 10.1523/JNEUROSCI.3742-14.2015 Pollay, 2010, The function and structure of the cerebrospinal fluid outflow system, Cerebrospinal Fluid Res., 7, 9, 10.1186/1743-8454-7-9 Rangroo Thrane, 2013, Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain, Sci. Rep., 3, 2582, 10.1038/srep02582 Rangroo Thrane, 2013, Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering, Nat. Med., 19, 1643, 10.1038/nm.3400 Rennels, 1985, Evidence for a ‘paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space, Brain Res., 326, 47, 10.1016/0006-8993(85)91383-6 Rolyan, 2011, Amyloid-beta protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease, J. Neural Transm., 118, 699, 10.1007/s00702-010-0572-7 Schoonenboom, 2005, Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?, Ann. Neurol., 58, 139, 10.1002/ana.20508 Selkoe, 2001, Clearing the brain's amyloid cobwebs, Neuron, 32, 177, 10.1016/S0896-6273(01)00475-5 Shibata, 2000, Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier, J. Clin. Invest., 106, 1489, 10.1172/JCI10498 Singh, 2013, Low levels of copper disrupt brain amyloid-beta homeostasis by altering its production and clearance, Proc. Natl. Acad. Sci. U. S. A., 110, 14771, 10.1073/pnas.1302212110 Suo, 1998, Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo, Neurosci. Lett., 257, 77, 10.1016/S0304-3940(98)00814-3 Thal, 2007, Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice, Neurobiol. Aging, 28, 1221, 10.1016/j.neurobiolaging.2006.05.029 Van Dorpe, 2000, Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons, Am. J. Pathol., 157, 1283, 10.1016/S0002-9440(10)64644-5 Walsh, 2002, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature, 416, 535, 10.1038/416535a Wang, 2012, Cognitive deficits and delayed neuronal loss in a mouse model of multiple microinfarcts, J. Neurosci., 32, 17948, 10.1523/JNEUROSCI.1860-12.2012 Weller, 1992, Pathways of fluid drainage from the brain–morphological aspects and immunological significance in rat and man, Brain Pathol., 2, 277, 10.1111/j.1750-3639.1992.tb00704.x Xie, 2013, Sleep drives metabolite clearance from the adult brain, Science, 342, 373, 10.1126/science.1241224 Xu, 2015, Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Abeta accumulation and memory deficits, Mol. Neurodegener., 10, 58, 10.1186/s13024-015-0056-1 Yamada, 1991, Albumin outflow into deep cervical lymph from different regions of rabbit brain, Am. J. Phys., 261, H1197 Yang, 2011, Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer's disease, J. Alzheimers Dis., 27, 711, 10.3233/JAD-2011-110725 Yang, 2013, Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer, J. Transl. Med., 11, 107, 10.1186/1479-5876-11-107 Yang, 2012, Aquaporin-4 mediates astrocyte response to beta-amyloid, Mol. Cell. Neurosci., 49, 406, 10.1016/j.mcn.2012.02.002 Zetterberg, 2007, Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years, J. Alzheimers Dis., 12, 255, 10.3233/JAD-2007-12307 Zhu, 2008, NG2 cells generate both oligodendrocytes and gray matter astrocytes, Development, 135, 145, 10.1242/dev.004895 Zlokovic, 2008, The blood-brain barrier in health and chronic neurodegenerative disorders, Neuron, 57, 178, 10.1016/j.neuron.2008.01.003 Zlokovic, 2008, New therapeutic targets in the neurovascular pathway in Alzheimer's disease, Neurotherapeutics, 5, 409, 10.1016/j.nurt.2008.05.011